Chang and colleagues found that depressed patients with hepatitis C treated with IFN- α had lower serum EPA levels and higher scores on neurotoxicity rating scale (NRS) for somatic symptoms compared to non-depressed patients (166). The gene discussed is IFNA1; the disease is hepatitis C virus infection.